Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease.

Arai T, Atsukawa M, Tsubota A, Koeda M, Yoshida Y, Okubo T, Nakagawa A, Itokawa N, Kondo C, Nakatsuka K, Masu T, Kato K, Shimada N, Hatori T, Emoto N, Kage M, Iwakiri K.

Dig Liver Dis. 2019 Jul;51(7):1036-1042. doi: 10.1016/j.dld.2018.12.022. Epub 2019 Jan 9.

PMID:
30683615
2.

Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression.

Masu T, Atsukawa M, Nakatsuka K, Shimizu M, Miura D, Arai T, Harimoto H, Kondo C, Kaneko K, Futagami S, Kawamoto C, Takahashi H, Iwakiri K.

PLoS One. 2018 Dec 31;13(12):e0200664. doi: 10.1371/journal.pone.0200664. eCollection 2018.

3.

Norepinephrine-induced downregulation of GLT-1 mRNA in rat astrocytes.

Kurita M, Matsuoka Y, Nakatsuka K, Ono D, Muto N, Kaku R, Morimatsu H.

Biochem Biophys Res Commun. 2018 Sep 26;504(1):103-108. doi: 10.1016/j.bbrc.2018.08.137. Epub 2018 Aug 28.

PMID:
30170732
4.

Burden of Human Metapneumovirus and Respiratory Syncytial Virus Infections in Asthmatic Children.

Furuta T, Hasegawa S, Mizutani M, Iwai T, Ohbuchi N, Kawano S, Tashiro N, Uchida M, Hasegawa M, Motoyama M, Sekino T, Nakatsuka K, Ichihara K, Shirabe K, Ohga S.

Pediatr Infect Dis J. 2018 Nov;37(11):1107-1111. doi: 10.1097/INF.0000000000002038.

PMID:
29742646
5.

Controlled Pyrolysis of Ni-MOF-74 as a Promising Precursor for the Creation of Highly Active Ni Nanocatalysts in Size-Selective Hydrogenation.

Nakatsuka K, Yoshii T, Kuwahara Y, Mori K, Yamashita H.

Chemistry. 2018 Jan 19;24(4):898-905. doi: 10.1002/chem.201704341. Epub 2017 Dec 12.

PMID:
29115699
6.

Epigastric pain syndrome accompanying pancreatic enzyme abnormalities was overlapped with early chronic pancreatitis using endosonography.

Hashimoto S, Futagami S, Yamawaki H, Kaneko K, Kodaka Y, Wakabayashi M, Sakasegawa N, Agawa S, Higuchi K, Akimoto T, Ueki N, Kawagoe T, Sato H, Nakatsuka K, Gudis K, Kawamoto C, Akamizu T, Sakamoto C, Iwakiri K.

J Clin Biochem Nutr. 2017 Sep;61(2):140-145. doi: 10.3164/jcbn.17-41. Epub 2017 Aug 18.

7.

Corrigendum to "A split G-quadruplex-based DNA nano-tweezers structure as a signal-transducing molecule for the homogeneous detection of specific nucleic acids" [Biosens. Bioelectron. 74 (2015) 222-226].

Nakatsuka K, Shigeto H, Kuroda A, Funabashi H.

Biosens Bioelectron. 2017 Aug 15;94:729. doi: 10.1016/j.bios.2017.03.019. Epub 2017 Mar 11. No abstract available.

PMID:
28292558
8.

Controlled synthesis of carbon-supported Co catalysts from single-sites to nanoparticles: characterization of the structural transformation and investigation of their oxidation catalysis.

Nakatsuka K, Yoshii T, Kuwahara Y, Mori K, Yamashita H.

Phys Chem Chem Phys. 2017 Feb 15;19(7):4967-4974. doi: 10.1039/c6cp06388h.

PMID:
27841416
9.

Mitochondrial peroxiredoxins are essential in regulating the relationship between Drosophila immunity and aging.

Odnokoz O, Nakatsuka K, Klichko VI, Nguyen J, Solis LC, Ostling K, Badinloo M, Orr WC, Radyuk SN.

Biochim Biophys Acta Mol Basis Dis. 2017 Jan;1863(1):68-80. doi: 10.1016/j.bbadis.2016.10.017. Epub 2016 Oct 19.

10.

Continuous Monitoring of Specific mRNA Expression Responses with a Fluorescence Resonance Energy Transfer-Based DNA Nano-tweezer Technique That Does Not Require Gene Recombination.

Shigeto H, Nakatsuka K, Ikeda T, Hirota R, Kuroda A, Funabashi H.

Anal Chem. 2016 Aug 16;88(16):7894-8. doi: 10.1021/acs.analchem.6b02710. Epub 2016 Jul 28.

PMID:
27458920
11.

Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance.

Nakatsuka K, Atsukawa M, Shimizu M, Takahashi H, Kawamoto C.

World J Hepatol. 2015 Nov 8;7(25):2590-6. doi: 10.4254/wjh.v7.i25.2590. Review.

12.

Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin.

Atsukawa M, Tsubota A, Shimada N, Yoshizawa K, Abe H, Asano T, Ohkubo Y, Araki M, Ikegami T, Okubo T, Kondo C, Osada Y, Nakatsuka K, Chuganji Y, Matsuzaki Y, Iwakiri K, Aizawa Y.

Hepatol Res. 2016 Mar;46(5):450-8. doi: 10.1111/hepr.12575. Epub 2015 Sep 17.

PMID:
26289410
13.

Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients.

Atsukawa M, Tsubota A, Shimada N, Yoshizawa K, Abe H, Asano T, Ohkubo Y, Araki M, Ikegami T, Kondo C, Itokawa N, Nakagawa A, Arai T, Matsushita Y, Nakatsuka K, Furihata T, Chuganji Y, Matsuzaki Y, Aizawa Y, Iwakiri K.

BMC Infect Dis. 2015 Aug 19;15:344. doi: 10.1186/s12879-015-1020-y.

14.

A split G-quadruplex-based DNA nano-tweezers structure as a signal-transducing molecule for the homogeneous detection of specific nucleic acids.

Nakatsuka K, Shigeto H, Kuroda A, Funabashi H.

Biosens Bioelectron. 2015 Dec 15;74:222-6. doi: 10.1016/j.bios.2015.06.055. Epub 2015 Jun 25. Erratum in: Biosens Bioelectron. 2017 Aug 15;94:729.

PMID:
26143462
15.

[Wide resection of chest wall for intramuscular lipoma in serratus anterior muscle reconstructed by autologous tissue;report of a case].

Mizuno K, Urabe N, Nakatsuka K, Ishikawa K, Eguchi M.

Kyobu Geka. 2015 Feb;68(2):157-9. Japanese.

PMID:
25743364
16.

Safety and efficacy of partial splenic embolization in telaprevir-based triple therapy for chronic hepatitis C.

Kondo C, Atsukawa M, Tsubota A, Shimada N, Abe H, Itokawa N, Nakagawa A, Fukuda T, Matsushita Y, Nakatsuka K, Kawamoto C, Iwakiri K, Aizawa Y, Sakamoto C.

Intern Med. 2015;54(2):119-26. doi: 10.2169/internalmedicine.54.3066. Epub 2015 Jan 15.

17.

A FRET-based DNA nano-tweezer technique for the imaging analysis of specific mRNA.

Funabashi H, Shigeto H, Nakatsuka K, Kuroda A.

Analyst. 2015 Feb 21;140(4):999-1003. doi: 10.1039/c4an02064b.

PMID:
25529369
18.

Relationship between HCV dynamics and sustained virological responses in chronic hepatitis C genotype 1b patients treated with telaprevir-based triple therapy.

Nakagawa A, Atsukawa M, Tsubota A, Shimada N, Abe H, Kondo C, Itokawa N, Arai T, Hashimoto S, Matsushita Y, Fukuda T, Nakatsuka K, Iwakiri K, Kawamoto C, Aizawa Y, Sakamoto C.

Eur J Gastroenterol Hepatol. 2014 Dec;26(12):1329-34. doi: 10.1097/MEG.0000000000000228.

PMID:
25357216
19.

Serum levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in human herpesvirus-6-infected infants with or without febrile seizures.

Kittaka S, Hasegawa S, Ito Y, Ohbuchi N, Suzuki E, Kawano S, Aoki Y, Nakatsuka K, Kudo K, Wakiguchi H, Kajimoto M, Matsushige T, Ichiyama T.

J Infect Chemother. 2014 Nov;20(11):716-21. doi: 10.1016/j.jiac.2014.07.017. Epub 2014 Aug 21.

PMID:
25156011
20.

Hydrophobic modification of Pd/SiO2 @single-site mesoporous silicas by triethoxyfluorosilane: enhanced catalytic activity and selectivity for one-pot oxidation.

Nakatsuka K, Mori K, Okada S, Ikurumi S, Kamegawa T, Yamashita H.

Chemistry. 2014 Jul 1;20(27):8348-54. doi: 10.1002/chem.201402586. Epub 2014 Jun 12.

PMID:
24920164
21.

Effect of fluvastatin on 24-week telaprevir-based combination therapy for hepatitis C virus genotype 1b-infected chronic hepatitis C.

Atsukawa M, Tsubota A, Shimada N, Kondo C, Itokawa N, Nakagawa A, Fukuda T, Matsushita Y, Narahara Y, Osada Y, Yamaguchi H, Nakatsuka K, Iwakiri K, Kawamoto C, Sakamoto C.

Eur J Gastroenterol Hepatol. 2014 Jul;26(7):781-7. doi: 10.1097/MEG.0000000000000105.

PMID:
24732752
22.

Serum 25-hydroxyvitamin D3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load.

Atsukawa M, Tsubota A, Shimada N, Kondo C, Itokawa N, Nakagawa A, Hashimoto S, Fukuda T, Matsushita Y, Narahara Y, Iwakiri K, Nakatsuka K, Kawamoto C, Sakamoto C.

Hepatol Res. 2014 Dec;44(13):1277-85. doi: 10.1111/hepr.12298. Epub 2014 Feb 26.

PMID:
24417888
23.

Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study.

Atsukawa M, Tsubota A, Shimada N, Kondo C, Itokawa N, Nakagawa A, Hashimoto S, Fukuda T, Matsushita Y, Kidokoro H, Narahara Y, Nakatsuka K, Iwakiri K, Kawamoto C, Sakamoto C.

Hepat Mon. 2013 Dec 23;13(12):e14872. doi: 10.5812/hepatmon.14872. eCollection 2013.

24.

Effects of fasudil on the portal and systemic hemodynamics of patients with cirrhosis.

Fukuda T, Narahara Y, Kanazawa H, Matsushita Y, Kidokoro H, Itokawa N, Kondo C, Atsukawa M, Nakatsuka K, Sakamoto C.

J Gastroenterol Hepatol. 2014 Feb;29(2):325-9. doi: 10.1111/jgh.12360.

PMID:
24033356
25.

Inactivation of tumor-specific CD8⁺ CTLs by tumor-infiltrating tolerogenic dendritic cells.

Harimoto H, Shimizu M, Nakagawa Y, Nakatsuka K, Wakabayashi A, Sakamoto C, Takahashi H.

Immunol Cell Biol. 2013 Oct;91(9):545-55. doi: 10.1038/icb.2013.38. Epub 2013 Sep 10. Erratum in: Immunol Cell Biol. 2013 Nov-Dec;91(10):665.

26.

High mobility group box 1 in patients with 2009 pandemic H1N1 influenza-associated encephalopathy.

Momonaka H, Hasegawa S, Matsushige T, Inoue H, Kajimoto M, Okada S, Nakatsuka K, Morishima T, Ichiyama T.

Brain Dev. 2014 Jun;36(6):484-8. doi: 10.1016/j.braindev.2013.07.001. Epub 2013 Jul 29.

PMID:
23907181
27.

Identification of molecular determinants for a potent mammalian TRPA1 antagonist by utilizing species differences.

Nakatsuka K, Gupta R, Saito S, Banzawa N, Takahashi K, Tominaga M, Ohta T.

J Mol Neurosci. 2013 Nov;51(3):754-62. doi: 10.1007/s12031-013-0060-2. Epub 2013 Jul 20.

PMID:
23872983
28.

Predictive factors for improvement of ascites after transjugular intrahepatic portosystemic shunt in patients with refractory ascites.

Taki Y, Kanazawa H, Narahara Y, Itokawa N, Kondo C, Fukuda T, Harimto H, Matsushita Y, Kidokoro H, Katakura T, Atsukawa M, Kimura Y, Nakatsuka K, Sakamoto C.

Hepatol Res. 2014 Aug;44(8):871-7. doi: 10.1111/hepr.12195. Epub 2013 Jul 25.

PMID:
23819607
29.

An in vitro model of cartilage degradation by chondrocytes in a three-dimensional culture system.

Nakashima K, Nakatsuka K, Yamashita K, Kenichi K, Taro H.

Int J Biomed Sci. 2012 Dec;8(4):249-57.

30.

Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype.

Itokawa N, Atsukawa M, Tsubota A, Kondo C, Hashimoto S, Fukuda T, Matsushita Y, Kidokoro H, Kobayashi T, Narahara Y, Nakatsuka K, Kanazawa H, Iwakiri K, Sakamoto C.

J Gastroenterol Hepatol. 2013 Mar;28(3):443-9. doi: 10.1111/jgh.12039.

PMID:
23173698
31.

Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b.

Atsukawa M, Tsubota A, Kondo C, Itokawa N, Narahara Y, Nakatsuka K, Hashimoto S, Fukuda T, Matsushita Y, Kidokoro H, Kobayashi T, Kanazawa H, Sakamoto C.

J Gastroenterol Hepatol. 2013 Jan;28(1):51-6. doi: 10.1111/j.1440-1746.2012.07267.x.

PMID:
22989264
32.

Effects of transjugular intrahepatic portosystemic shunt on changes in the small bowel mucosa of cirrhotic patients with portal hypertension.

Matsushita Y, Narahara Y, Fujimori S, Kanazawa H, Itokawa N, Fukuda T, Takahashi Y, Kondo C, Kidokoro H, Atsukawa M, Nakatsuka K, Sakamoto C.

J Gastroenterol. 2013 May;48(5):633-9. doi: 10.1007/s00535-012-0660-6. Epub 2012 Sep 13.

PMID:
22968470
33.

Ribavirin modulates the conversion of human CD4(+)  CD25(-) T cell to CD4(+)  CD25(+)  FOXP3(+) T cell via suppressing interleukin-10-producing regulatory T cell.

Kobayashi T, Nakatsuka K, Shimizu M, Tamura H, Shinya E, Atsukawa M, Harimoto H, Takahashi H, Sakamoto C.

Immunology. 2012 Nov;137(3):259-70. doi: 10.1111/imm.12005.

34.

An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin.

Kondo C, Atsukawa M, Tsubota A, Itokawa N, Fukuda T, Matsushita Y, Kidokoro H, Kobayashi T, Narahara Y, Nakatsuka K, Kanazawa H, Sakamoto C.

J Viral Hepat. 2012 Sep;19(9):615-22. doi: 10.1111/j.1365-2893.2011.01584.x. Epub 2012 Feb 9.

PMID:
22863265
35.

Analysis of transient receptor potential ankyrin 1 (TRPA1) in frogs and lizards illuminates both nociceptive heat and chemical sensitivities and coexpression with TRP vanilloid 1 (TRPV1) in ancestral vertebrates.

Saito S, Nakatsuka K, Takahashi K, Fukuta N, Imagawa T, Ohta T, Tominaga M.

J Biol Chem. 2012 Aug 31;287(36):30743-54. doi: 10.1074/jbc.M112.362194. Epub 2012 Jul 12.

36.

Wolf Motor Function Test for characterizing moderate to severe hemiparesis in stroke patients.

Hodics TM, Nakatsuka K, Upreti B, Alex A, Smith PS, Pezzullo JC.

Arch Phys Med Rehabil. 2012 Nov;93(11):1963-7. doi: 10.1016/j.apmr.2012.05.002. Epub 2012 May 10.

37.

Screening of PC and PMMA-binding peptides for site-specific immobilization of proteins.

Kumada Y, Murata S, Ishikawa Y, Nakatsuka K, Kishimoto M.

J Biotechnol. 2012 Aug 31;160(3-4):222-8. doi: 10.1016/j.jbiotec.2012.02.010. Epub 2012 Mar 16.

PMID:
22426519
38.

Stiles-Crawford effect in focal macular ERGs from macaque monkey.

Matsumoto CS, Shinoda K, Matsumoto H, Satofuka S, Mizota A, Nakatsuka K, Miyake Y.

J Vis. 2012 Mar 6;12(3). pii: 6. doi: 10.1167/12.3.6.

PMID:
22396466
39.

A case of IgG4-related disease with rectal cancer.

Itokawa N, Atsukawa M, Nishino T, Kondo C, Fukuda T, Matsushita Y, Kidokoro H, Katakura T, Narahara Y, Tanaka S, Nakatsuka K, Oaki Y, Sakamoto C.

Clin J Gastroenterol. 2011 Dec;4(6):374-80. doi: 10.1007/s12328-011-0253-6. Epub 2011 Sep 22.

PMID:
26189739
40.

Gender differences in maximum voluntary lip-closing force during lip pursing in healthy young adults.

Murakami M, Adachi T, Nakatsuka K, Kato T, Oishi M, Masuda Y.

J Oral Rehabil. 2012 Jun;39(6):399-404. doi: 10.1111/j.1365-2842.2011.02268.x. Epub 2011 Nov 24.

PMID:
22115393
41.

Ribavirin downmodulates inducible costimulator on CD4+ T cells and their interleukin-10 secretion to assist in hepatitis C virus clearance.

Atsukawa M, Nakatsuka K, Kobayashi T, Shimizu M, Tamura H, Harimoto H, Takahashi H, Sakamoto C.

J Gastroenterol Hepatol. 2012 Apr;27(4):823-31. doi: 10.1111/j.1440-1746.2011.06882.x.

PMID:
21871023
42.

The PI3K/Akt pathway mediates the expression of type I collagen induced by TGF-β2 in human retinal pigment epithelial cells.

Yokoyama K, Kimoto K, Itoh Y, Nakatsuka K, Matsuo N, Yoshioka H, Kubota T.

Graefes Arch Clin Exp Ophthalmol. 2012 Jan;250(1):15-23. doi: 10.1007/s00417-011-1766-x. Epub 2011 Aug 20.

43.

Asymmetric lip-closing forces in children with repaired unilateral cleft lip and/or palate.

Nakatsuka K, Adachi T, Kato T, Murakami M, Yamada K, Masuda Y.

J Oral Rehabil. 2011 Dec;38(12):921-8. doi: 10.1111/j.1365-2842.2011.02237.x. Epub 2011 Jul 25.

PMID:
21790715
44.

Unusual protrusion of conjunctiva in two neonates with harlequin ichthyosis.

Hazuku T, Yamada K, Imaizumi M, Ikebe T, Shinoda K, Nakatsuka K, Sekiguchi K, Izumi T, Nishida Y.

Case Rep Ophthalmol. 2011 Feb 21;2(1):73-7. doi: 10.1159/000325138.

45.

High correlation of scotopic and photopic electroretinogram components with severity of central retinal artery occlusion.

Matsumoto CS, Shinoda K, Nakatsuka K.

Clin Ophthalmol. 2011 Jan 20;5:115-21. doi: 10.2147/OPTH.S16053.

46.

Regulatory relationship between tactile sensation at the vermilion of the lips and lip-closing force.

Nakatsuka K, Adachi T, Kato T, Oishi M, Masuda Y.

J Oral Rehabil. 2011 Aug;38(8):579-87. doi: 10.1111/j.1365-2842.2010.02198.x. Epub 2011 Jan 20.

PMID:
21251043
47.

Optical coherence tomographic assessment of dynamic macular changes in patients with Vogt-Koyanagi-Harada disease.

Ikewaki J, Kimoto K, Choshi T, Nagata M, Motomura Y, Tamura K, Shinoda K, Nakatsuka K.

Int Ophthalmol. 2011 Feb;31(1):9-13. doi: 10.1007/s10792-010-9412-x. Epub 2010 Dec 31.

PMID:
21194005
48.

Two Cases of Endogenous Endophthalmitis Caused by Gram-Positive Bacteria with Good Visual Outcome.

Itoh M, Ikewaki J, Kimoto K, Itoh Y, Shinoda K, Nakatsuka K.

Case Rep Ophthalmol. 2010 Sep 21;1(2):56-62.

49.

Cystoid Macular Edema: Possible Complication of Infliximab Therapy in Behçet's Disease.

Ikewaki J, Kono H, Shinoda K, Kubota T, Nakatsuka K.

Case Rep Ophthalmol. 2010 Jun 11;1(1):14-19.

50.

Reliability of novel multidirectional lip-closing force measurement system.

Nakatsuka K, Adachi T, Kato T, Oishi M, Murakami M, Okada Y, Masuda Y.

J Oral Rehabil. 2011 Jan;38(1):18-26. doi: 10.1111/j.1365-2842.2010.02129.x. Epub 2010 Aug 15.

PMID:
20722773

Supplemental Content

Loading ...
Support Center